Headlines

Pinduoduo And 7 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

(VIANEWS) – Pinduoduo (PDD), Kiniksa Pharmaceuticals, Ltd. (KNSA), Palantir (PLTR) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Pinduoduo (PDD)

116.5% sales growth and 34.33% return on equity

PDD Holdings Inc., a multinational commerce group, owns and operates a portfolio of businesses. It operates Pinduoduo, an e-commerce platform that offers products in various categories, including agricultural produce, apparel, shoes, bags, mother and childcare products, food and beverage, electronic appliances, furniture and household goods, cosmetics and other personal care, sports and fitness items and auto accessories; and Temu, an online marketplace. It focuses on bringing businesses and people into the digital economy. The company was formerly known as Pinduoduo Inc. and changed its name to PDD Holdings Inc. in February 2023. PDD Holdings Inc. was incorporated in 2015 and is based in Dublin, Ireland.

Earnings Per Share

As for profitability, Pinduoduo has a trailing twelve months EPS of $4.39.

PE Ratio

Pinduoduo has a trailing twelve months price to earnings ratio of 27.86. Meaning, the purchaser of the share is investing $27.86 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 34.33%.

Sales Growth

Pinduoduo’s sales growth is 94.2% for the ongoing quarter and 116.5% for the next.

Revenue Growth

Year-on-year quarterly revenue growth grew by 93.9%, now sitting on 198.58B for the twelve trailing months.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is 34.5% and 1%, respectively.

Yearly Top and Bottom Value

Pinduoduo’s stock is valued at $122.30 at 06:22 EST, way below its 52-week high of $152.99 and way above its 52-week low of $59.67.

2. Kiniksa Pharmaceuticals, Ltd. (KNSA)

24.1% sales growth and 3.37% return on equity

Kiniksa Pharmaceuticals, Ltd., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need worldwide. Its product candidates include Rilonacept, which is in Phase III clinical trials for the treatment of recurrent pericarditis, an inflammatory cardiovascular disease; Mavrilimumab, a monoclonal antibody that is in Phase II clinical trials for the treatment of giant cell arteritis; and Vixarelimab, a monoclonal antibody, which is in Phase 2a clinical trial for the treatment of prurigo nodularis, a chronic inflammatory skin condition. The company's preclinical product candidates comprise KPL-404, a monoclonal antibody inhibitor of the CD40/CD40L interaction, a central control node of T-cell-dependent, and B-cell-mediated humoral adaptive immunity. The company has a clinical collaboration with Kite Pharma, Inc. to evaluate the combination of Yescarta and Mavrilimumab in patients with relapsed or refractory Large B-Cell lymphoma. Kiniksa Pharmaceuticals, Ltd. was founded in 2015 and is based in Hamilton, Bermuda.

Earnings Per Share

As for profitability, Kiniksa Pharmaceuticals, Ltd. has a trailing twelve months EPS of $0.2.

PE Ratio

Kiniksa Pharmaceuticals, Ltd. has a trailing twelve months price to earnings ratio of 102.2. Meaning, the purchaser of the share is investing $102.2 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.37%.

Volume

Today’s last reported volume for Kiniksa Pharmaceuticals, Ltd. is 327405 which is 27.75% below its average volume of 453180.

Moving Average

Kiniksa Pharmaceuticals, Ltd.’s worth is above its 50-day moving average of $19.39 and way higher than its 200-day moving average of $17.12.

Sales Growth

Kiniksa Pharmaceuticals, Ltd.’s sales growth is 62.3% for the ongoing quarter and 24.1% for the next.

Growth Estimates Quarters

The company’s growth estimates for the present quarter is 5.6% and a drop 152.4% for the next.

3. Palantir (PLTR)

17.2% sales growth and 5.44% return on equity

Palantir Technologies Inc. builds and deploys software platforms for the intelligence community to assist in counterterrorism investigations and operations in the United States, the United Kingdom, and internationally. The company provides Palantir Gotham, a software platform which enables users to identify patterns hidden deep within datasets, ranging from signals intelligence sources to reports from confidential informants, as well as facilitates the handoff between analysts and operational users, helping operators plan and execute real-world responses to threats that have been identified within the platform. It also offers Palantir Foundry, a platform that transforms the ways organizations operate by creating a central operating system for their data; and allows individual users to integrate and analyze the data they need in one place. In addition, it provides Palantir Apollo, a software that delivers software and updates across the business, as well as enables customers to deploy their software virtually in any environment; and Palantir Artificial Intelligence Platform (AIP) that provides unified access to open-source, self-hosted, and commercial large language models (LLM) that can transform structured and unstructured data into LLM-understandable objects and can turn organizations' actions and processes into tools for humans and LLM-driven agents. The company was incorporated in 2003 and is headquartered in Denver, Colorado.

Earnings Per Share

As for profitability, Palantir has a trailing twelve months EPS of $0.09.

PE Ratio

Palantir has a trailing twelve months price to earnings ratio of 272. Meaning, the purchaser of the share is investing $272 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.44%.

Previous days news about Palantir(PLTR)

  • Palantir technologies inc. (pltr) stock falls amid market uptick: what investors need to know. According to Zacks on Tuesday, 19 March, "The most recent trading session ended with Palantir Technologies Inc. (PLTR Quick QuotePLTR – Free Report) standing at $23.80, reflecting a -0.83% shift from the previouse trading day’s closing. ", "Investors will be eagerly watching for the performance of Palantir Technologies Inc. in its upcoming earnings disclosure. "

4. PNM Resources (PNM)

10.9% sales growth and 4.56% return on equity

PNM Resources, Inc., through its subsidiaries, provides electricity and electric services in the United States. It operates through Public Service Company of New Mexico (PNM) and Texas-New Mexico Power Company (TNMP) segments. The PNM segment engages in the generation, transmission, and distribution of electricity. The segment owns and leases communication, office and other equipment, office space, vehicles, and real estate. It generates electricity using coal, natural gas and oil, nuclear fuel, solar, wind, and geothermal energy sources. The TNMP segment provides regulated transmission and distribution services. The segment also owns and leases vehicles, service facilities, and office locations throughout its service territory. The company serves residential, commercial, and industrial customers and end-users of electricity in New Mexico and Texas. PNM Resources, Inc. was founded in 1882 and is headquartered in Albuquerque, New Mexico.

Earnings Per Share

As for profitability, PNM Resources has a trailing twelve months EPS of $1.02.

PE Ratio

PNM Resources has a trailing twelve months price to earnings ratio of 36.08. Meaning, the purchaser of the share is investing $36.08 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.56%.

Sales Growth

PNM Resources’s sales growth is 1.3% for the present quarter and 10.9% for the next.

Revenue Growth

Year-on-year quarterly revenue growth declined by 28.4%, now sitting on 1.94B for the twelve trailing months.

Earnings Before Interest, Taxes, Depreciation, and Amortization

PNM Resources’s EBITDA is 4.28.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is a negative 18.2% and a negative 5.5%, respectively.

5. WEX (WEX)

8.9% sales growth and 15.37% return on equity

WEX Inc. operates a commerce platform in the United States and internationally. The Fleet Solutions segment offers fleet vehicle payment solutions, transaction processing, and information management services. It also provides account and account retention services; authorization and billing inquiries, and account maintenance services; account management; credit and collections services; merchant services; analytics solutions; and ancillary services and tools to fleets to manage expenses and capital requirements. This segment markets its products directly and indirectly to businesses and government agencies with fleets of commercial vehicles; and indirectly through co-branded and private label relationships. The Travel and Corporate Solutions segment provides payment solutions, including embedded payments; and accounts payable automation and spend management solutions. Its products include virtual cards that are used for transactions where no physical card is presented. This segment markets its products directly and indirectly to customers in travel, fintech, insurance, consumer bill pay, and media verticals, as well as businesses and financial institutions. The Health and Employee Benefit Solutions segment offers software-as-a-service (SaaS) platform for consumer directed healthcare benefits and full-service benefit enrollment solutions. Its SaaS platform includes embedded payment solutions and plan administration services for consumer-directed health benefits; COBRA accounts; and benefit enrollment and administration services. This segment also provides custodial and depository services for health savings accounts; and payroll-related benefits. This segment markets its products through third-party administrators, financial institutions, payroll providers, and health plans. The company was formerly known as Wright Express Corporation and changed its name to WEX Inc. in October 2012. WEX Inc. was founded in 1983 and is based in Portland, Maine.

Earnings Per Share

As for profitability, WEX has a trailing twelve months EPS of $6.16.

PE Ratio

WEX has a trailing twelve months price to earnings ratio of 38.31. Meaning, the purchaser of the share is investing $38.31 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.37%.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is 4.5% and 9.4%, respectively.

Moving Average

WEX’s value is above its 50-day moving average of $214.60 and way above its 200-day moving average of $193.33.

Sales Growth

WEX’s sales growth is 8.3% for the present quarter and 8.9% for the next.

Volume

Today’s last reported volume for WEX is 147062 which is 52.27% below its average volume of 308115.

6. CBIZ (CBZ)

8.1% sales growth and 16.08% return on equity

CBIZ, Inc. provides financial, insurance, and advisory services in the United States and Canada. The company operates through three segments: Financial Services, Benefits and Insurance Services, and National Practices. The Financial Services segment offers accounting and tax, government healthcare consulting, financial advisory, valuation, and risk and advisory services. The Benefits and Insurance Services provides group health benefits consulting, payroll, property and casualty, and retirement plan services. The National Practices segment offers managed networking and hardware, and health care consulting services. It primarily serves small and medium-sized businesses, as well as individuals, governmental entities, and not-for-profit enterprises. The company was founded in 1987 and is headquartered in Cleveland, Ohio.

Earnings Per Share

As for profitability, CBIZ has a trailing twelve months EPS of $2.39.

PE Ratio

CBIZ has a trailing twelve months price to earnings ratio of 31.46. Meaning, the purchaser of the share is investing $31.46 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.08%.

7. Canadian Pacific Railway (CP)

7.9% sales growth and 9.65% return on equity

Canadian Pacific Kansas City Limited, together with its subsidiaries, owns and operates a transcontinental freight railway in Canada, the United States, and Mexico. The company transports bulk commodities, including grain, coal, potash, fertilizers, and sulphur; merchandise freight, such as forest products, energy, chemicals and plastics, metals, minerals, consumer products, and automotive; and intermodal traffic comprising retail goods in overseas containers. It also provides rail and intermodal transportation services over a network of approximately 20,000 miles serving business centres. The company was formerly known as Canadian Pacific Railway Limited and changed its name to Canadian Pacific Kansas City Limited in April 2023. Canadian Pacific Kansas City Limited was incorporated in 1881 and is headquartered in Calgary, Canada.

Earnings Per Share

As for profitability, Canadian Pacific Railway has a trailing twelve months EPS of $3.11.

PE Ratio

Canadian Pacific Railway has a trailing twelve months price to earnings ratio of 28.94. Meaning, the purchaser of the share is investing $28.94 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.65%.

Volume

Today’s last reported volume for Canadian Pacific Railway is 2082530 which is 3.92% below its average volume of 2167620.

Sales Growth

Canadian Pacific Railway’s sales growth is 53.1% for the ongoing quarter and 7.9% for the next.

Yearly Top and Bottom Value

Canadian Pacific Railway’s stock is valued at $90.00 at 06:22 EST, below its 52-week high of $91.04 and way higher than its 52-week low of $68.92.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is 4.4% and 17.7%, respectively.

8. Titan Machinery (TITN)

7.9% sales growth and 18.75% return on equity

Titan Machinery Inc. owns and operates a network of full-service agricultural and construction equipment stores in the United States and Europe. It operates through three segments: Agriculture, Construction, and International. The company sells new and used equipment, including agricultural and construction equipment manufactured under the CNH Industrial family of brands, as well as equipment from various other manufacturers. Its agricultural equipment includes machinery and attachments for use in the production of food, fiber, feed grain, and renewable energy; and home and garden applications, as well as maintenance of commercial, residential, and government properties. The company's construction equipment comprises heavy construction machinery, light industrial machinery for commercial and residential construction, road and highway construction machinery, and energy and forestry operations equipment. It also sells maintenance and replacement parts. In addition, the company offers repair and maintenance services that include warranty repairs, off-site and on-site repair services, scheduling off-season maintenance services, and notifying customers of periodic service requirements; and training programs to customers. Further, it rents equipment; and provides ancillary equipment support services, such as equipment transportation, global positioning system signal subscriptions and other precision farming products, farm data management products, and CNH Industrial finance and insurance products. The company operates in Colorado, Iowa, Minnesota, Montana, Nebraska, North Dakota, South Dakota, Wisconsin, and Wyoming, the United States; and Bulgaria, Germany, Romania, Serbia, and Ukraine, Europe. Titan Machinery Inc. was founded in 1980 and is headquartered in West Fargo, North Dakota.

Earnings Per Share

As for profitability, Titan Machinery has a trailing twelve months EPS of $4.67.

PE Ratio

Titan Machinery has a trailing twelve months price to earnings ratio of 5.39. Meaning, the purchaser of the share is investing $5.39 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.75%.

Yearly Top and Bottom Value

Titan Machinery’s stock is valued at $25.17 at 06:22 EST, way under its 52-week high of $43.11 and way higher than its 52-week low of $21.44.

Sales Growth

Titan Machinery’s sales growth is 24.2% for the ongoing quarter and 7.9% for the next.

Growth Estimates Quarters

The company’s growth estimates for the current quarter is 25.9% and a drop 18.5% for the next.

Previous days news about Titan Machinery(TITN)

  • Compared to estimates, titan machinery (titn) Q4 earnings: A look at key metrics. According to Zacks on Thursday, 21 March, "Here is how Titan Machinery performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:"

Leave a Reply

Your email address will not be published. Required fields are marked *